This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 9763808
Submitted by lobbyist on: April 11, 2012 01:47:15 AM
Accepted by Registrar on: April 12, 2012 03:55:30 PM
Designated Filer Information
| Gilbert, Dominique |
| 1000 de la Gauchetiere West Suite 500 | |
|
Montreal, QC, H3B 4W5
|
514-940-9982 |
| Canada |
Organization Information
| Lundbeck Canada Inc. |
| Lundbeck Canada develops, manufactures and/or sells innovative biopharmaceutical products for the treatment of disorders originating in the central nervous system and for the treatment of cancer. |
| 1000 de la Gauchetiere West Suite 500 | |
|
Montreal, QC, H3B 4W5
|
514-940-9982 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| H. Lundbeck a/s |
9 Ottilavej
Copenhagen Valby DK-2500, Denmark |
Phone: 5149409426 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| April 11, 2012 | |
| November 14, 2012 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
To introduce the Lundbeck organization and its portfolio of oncology-related products and services to the Ministry of Health and known public cancer agencies in British Columbia.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Other Public Agency Contact | BC Cancer Agency | March 30, 2012 | |
| Minister | de Jong, Mike | Minister of Health | March 30, 2012 |
| Public Agency | Health | March 30, 2012 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Meet, discuss and negotiate with staff within the Pharmaceutical Services Division, Health Services Authority and/or Cancer agencies, as appropriate, with respect to access and reimbursement listing decisions for Lundbeck Canada's oncology medicines.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Other Public Agency Contact | BC Cancer Agency | March 30, 2012 | |
| Public Agency | Health | March 30, 2012 | |
| Public Agency | Provincial Health Services Authority | March 30, 2012 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
To introduce the Lundbeck organization and its product portfolio and services to the Ministry of Health and known public cancer agencies in British Columbia.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Other Public Agency Contact | BC Cancer Agency | March 30, 2012 | |
| Minister | de Jong, Mike | Minister of Health | March 30, 2012 |
| Public Agency | Health | March 30, 2012 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Meet, discuss and negotiate with staff within the Pharmaceutical Services Division, Health Services Authority and/or Cancer agencies, as appropriate, with respect to access and reimbursement listing decisions for Lundbeck Canada's portfolio of medicines.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Other Public Agency Contact | BC Cancer Agency | March 30, 2012 | |
| Public Agency | Health | March 30, 2012 | |
| Public Agency | Provincial Health Services Authority | March 30, 2012 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
To introduce the Lundbeck organization and its portfolio of innovative medicines for the treatment of mental health disorders and related CNS diseases to the Ministry of Health.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | de Jong, Mike | Minister of Health | March 30, 2012 |
| Public Agency | Health | March 30, 2012 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Meet, discuss and negotiate with staff within the Pharmaceutical Services Division and BC Health Services Authority with respect to access and reimbursement listing decisions for Lundbeck Canada's portfolio of medicines for the treatment of Central Nervous System disorders.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 30, 2012 | |
| Public Agency | Provincial Health Services Authority | March 30, 2012 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
To introduce the Lundbeck organization and its portfolio of oncology-related products and services to the Ministry of Health and known public cancer agencies in British Columbia.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Other Public Agency Contact | BC Cancer Agency | March 30, 2012 | |
| Minister | de Jong, Mike | Minister of Health | March 30, 2012 |
| Public Agency | Health | March 30, 2012 |
Health
Development, establishment, amendment or termination of any program, policy or decision
Meet, discuss and negotiate with staff within the Pharmaceutical Services Division, Health Services Authority and/or Cancer agencies, as appropriate, with respect to access and reimbursement listing decisions for Lundbeck Canada's oncology medicines.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Other Public Agency Contact | BC Cancer Agency | March 30, 2012 | |
| Public Agency | Health | March 30, 2012 | |
| Public Agency | Provincial Health Services Authority | March 30, 2012 |